Monitoring of long-term toxicities of HIV treatments: an international perspective

被引:29
作者
Bisson, G
Gross, R
Miller, V
Weller, I
Walker, A
机构
[1] Forum Collaborat HIV Res Workshop, Washington, DC 20006 USA
[2] Univ Penn, Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA
[3] UCL Royal Free & Univ Coll, Sch Med, Dept Sexually Transmitted Dis, London, England
[4] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
关键词
drug safety monitoring; pharmacovigilance; pharmacoepidemiology; risk management;
D O I
10.1097/00002030-200311210-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:2407 / 2417
页数:11
相关论文
共 25 条
  • [1] Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008
  • [2] Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy
    Antinori, A
    Baldini, F
    Girardi, E
    Cingolani, A
    Zaccarelli, M
    Di Giambenedetto, S
    Barracchini, A
    De Longis, P
    Murri, R
    Tozzi, V
    Ammassari, A
    Rizzo, MG
    Ippolito, G
    De Luca, A
    [J]. AIDS, 2001, 15 (12) : 1579 - 1581
  • [3] Improving the quality of reporting of randomized controlled trials - The CONSORT statement
    Begg, C
    Cho, M
    Eastwood, S
    Horton, R
    Moher, D
    Olkin, I
    Pitkin, R
    Rennie, D
    Schulz, KF
    Simel, D
    Stroup, DF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08): : 637 - 639
  • [4] The Medical Dictionary for Regulatory Activities (MedDRA)
    Brown, EG
    Wood, L
    Wood, S
    [J]. DRUG SAFETY, 1999, 20 (02) : 109 - 117
  • [5] An objective case definition of lipodystrophy in HIV-infected adults: a case-control study
    Carr, A
    Emery, S
    Law, I
    Puls, R
    Lundgren, JD
    Powderly, WG
    Carr, B
    Cooper, DA
    Grinspoon, S
    Ioannidis, J
    Lewis, R
    Law, M
    Lichtenstein, K
    Murray, J
    Pizzuti, D
    Rozenbaum, W
    Schambelan, M
    Moore, A
    Miller, J
    [J]. LANCET, 2003, 361 (9359) : 726 - 735
  • [6] Improvement of the study, analysis, and reporting of adverse events associated with antiretroviral therapy
    Carr, A
    [J]. LANCET, 2002, 360 (9326) : 81 - 85
  • [7] HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study
    Carr, A
    Hudson, J
    Chuah, J
    Mallal, S
    Law, M
    Hoy, J
    Doong, N
    French, M
    Smith, D
    Cooper, DA
    [J]. AIDS, 2001, 15 (14) : 1811 - 1822
  • [8] Carson J., 2000, Pharmacoepidemiology, V3rd, P307
  • [9] Duran S, 2001, HIV Clin Trials, V2, P38
  • [10] Eland IA, 1999, BRIT J CLIN PHARMACO, V48, P623